Report: Medtech spending, pricing barely budged in more than 20 years

Medical devices are often at the center of healthcare spending debates, but a new report released by medical device industry lobbying group AdvaMed concluded that "medical devices are a relatively small and  very  slowly growing share of national health expenditures."

In a study commissioned by AdvaMed, researchers found that medical device spending as a share of national health expenditures barely budged between 1989 and 2010, growing from 5.3% of overall costs to 6.0%. Most of that growth occurred prior to 1992 and since then medtech spending has represented about 6% of U.S. health spending, researchers noted.

The new study builds on a previous report, which considered the period between 1989 and 2009 and which AdvaMed released last year.

"The findings underscore the tremendous value medical technology provides to patients and the overall health care system," AdvaMed payment & healthcare delivery policy executive vice president Anne-Marie Lynch said in prepared remarks. "Unlike other areas of health care, the prices of medical devices have been growing much more slowly not only as compared to the Medical Consumer Price Index but also as compared to the CPI as a whole."

Medical device prices have also grown more slowly than average prices nationwide according to the report, which was conducted by Roland "Guy" King, the former chief actuary for what is now known as the Centers for Medicare & Medicaid Services. The agency was known as the Health Care Financing Administration during King’s time.

During the most recent 10-year period, ending in 2010, medical device prices increased at an average rate of 1%, the report concluded. That compared with 4.1% for the overall Medicare Care Consumer Price Index and 2.4% for the general Consumer Price Index. Medtech prices gained 0.1% from 2009 to 2010, the period between AdvaMed’s last and latest report.

"In view of the conventional wisdom about the role of medical technology in driving up costs, it is surprising that the cost of medical devices has risen little as a share of total national health expenditures," the researchers wrote. "It is also striking that, unlike most other areas of medicine, the prices of medical devices have actually been growing more slowly not only than the MC-CPI but also the CPI as a whole."

The study included medical device and diagnostics pricing and spending over a 22 year period, excluding laboratory apparatus and furniture, dental equipment and supplies, dental laboratories and diagnostics substances, according to the report.

The news comes as AdvaMed and medical device advocates continue working to repeal the 2.3% medical device tax that’s set to take effect at the beginning of next year. The measure, contained in President Barack Obama’s landmark Affordable Care Act, is expected to raise $30 billion over the next 10 years through a levy on domestic sales of medical devices.

Recent analyses suggest that the industry’s effort to push repeal through a lame-duck Congress aren’t likely to succeed, but a motion to spike the levy could ride along on bigger bill if key Senate Democrats go along.

The new study may help make some inroads by helping to dispel perceptions that the medical device industry is a prime driver of increased healthcare spending in the U.S. Earlier this year the Bipartisan Policy Center released a report concluding that overuse of expensive and unnecessary medtech innovations is among the primary sources of the skyrocketing cost of healthcare in the U.S.

"We are proud of the value we deliver as an industry to patients worldwide and look forward to sharing the results of this new study with Members of Congress and other policymakers as they consider changes to the health care delivery and payment system in the United States," AdvaMed’s Lynch said.

RSS From Medical Design & Outsourcing

  • Athermal laser machining cuts bioabsorbable polymers and more
    A the recent MD&M East trade show in New York, Norman Noble, discussed the capability of athermal laser manufacturer. The company has developed the Noble S.T.E.A.L.T.H. (System To Enable Ablation Laser Technology Haz-free). The athermal laser machining process was developed to create precise features in any material, including bioabsorbable polymers, shape memory metals and other […]
  • Exciting possibilities for metallic glass in the medical device world
    Researchers are exploring the potential of metallic glass as a versatile, pliable material that is stronger than steel, with a bevy of possible medical device applications. Yale University engineers have discovered a unique method for designing metallic glass nanostructures across a wide range of chemicals, a technique that could have applications for everything from watch […]
  • Strong Precision Technologies’ medical divisions to unify under MedTorque brand
    Strong Precision Technologies announced on July 2, 2015, that its two medical divisions will now go to market under a single brand, MedTorque. The move reflects the increasing integration of the division formerly known as Inland Midwest with MedTorque, its sister division in Kenosha, WI. “We will continue providing our customers with the personalized level of service […]
  • Olympus offers next-day product replacement guarantee for medical devices
    Olympus, a medical and surgical procedures solutions company, announced that it is guaranteeing next-day replacements for surgical equipment at no additional charge. Olympus is the first surgical product manufacturer to offer this type of guarantee. The service became available to customers with an Olympus Full Service Agreement earlier this year. “Canceled procedures can be costly for healthcare facilities […]
  • More accurate prediction on prognosis in multiple myeloma from SkylineDx
    SkylineDx, a biotechnology company specializing in the development and commercialization of genetic tests, is launching its MMprofiler assay. This test enables clinicians to more accurately predict the prognosis of patients with multiple myeloma (bone marrow cancer) than traditional methods. The MMprofiler measures the activity of 92 genes which are directly or indirectly related to the […]
  • Flint Mobile swaps card reader for camera, accept mobile payments anywhere
    Flint Mobile, the swipe-free mobile payments app, has significantly expanded its payment management and loyalty capabilities for small, service-centric businesses, like the ones run by on-the-go medical equipment professionals. The toggle-free mobile technology makes the process quite simple for both parties, as all transactions are conducted through the mobile device’s camera without the need of any external […]
  • Should scientists be allowed to genetically alter human embryos?
    Scientists have at their disposal, a way to explore the possible prevention of genetic diseases before birth. But should they? Currently, the most promising path forward involves editing the genes of human embryos, a procedure threaded with controversy. An article in “Chemical & Engineering News” (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), parses […]
  • Tackling chronic sinusitis by addressing underlying factors
    The stuffy noses and sinus pressure of head colds are uncomfortable, but for most people, they go away within days. For those with chronic sinusitis, however, those symptoms and others drag on for weeks. Now scientists are onto a potential new therapy that could address one of the underlying factors associated with the condition. They […]
  • Implantable “artificial pancreas” could help diabetes patients control their blood sugar
    Living with Type 1 diabetes requires constant monitoring of blood sugar levels and injecting insulin daily. Now scientists are reporting in the American Chemical Society (ACS) journal, “Industrial & Engineering Chemistry Research,” the development of an implantable “artificial pancreas” that continuously measures a person’s blood sugar or glucose level and can automatically release insulin as […]
  • Drug Deactivation program roll out to all facilities for safe disposal of unused prescription medications
    Verde Technologies announced that New Brighton-based Meridian Behavioral Health, the largest for-profit substance abuse and addiction treatment group in Minnesota, has become its most recent partner in the deactivation and safe disposal of prescription medications including methadone. Meridian is the first behavioral health group to roll out the Deterra Drug Deactivation System to all 17 […]
  • Lophius Biosciences introduces T-activated ImmunoScan Cocktail
    Lophius Biosciences announced the commercial launch of T-Track ImmunoScan and T-activated ImmunoScan Cocktail. Based on a proprietary and very specific cocktail of stimulants in combination with the Company’s T-activation technology, T-Track ImmunoScan and T-activated ImmunoScan Cocktail specifically target different cell types involved in both the adaptive and innate immune system. T-Track ImmunoScan and the T-activated […]

Leave a Reply